+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 39Years
All Genders
ID07692763

Pilot Trial of the Young Adults Taking Action YATAC Rehabilitation Program for Cancer Patients Aged 18 to 39

Led by University of Aarhus · Updated on 2026-07-10

50

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Young adults aged 18 to 39 years who have cancer often face physical, psychological, and social challenges that affect their daily life and quality of life. Current cancer rehabilitation programs rarely address the specific needs of this age group. The Young Adults Taking Action YATAC programme was created with input from young adults with cancer, healthcare professionals, and researchers to offer age-specific support for managing cancer-related challenges and helping young adults return to everyday activities. This pilot randomized controlled trial aims to assess the feasibility of conducting a larger study of the YATAC programme within municipal rehabilitation services in Aarhus Municipality, Denmark. Participants will be randomly assigned to one of two groups the 16-week YATAC programme or standard cancer rehabilitation services. The YATAC programme includes an individual needs assessment and goal-setting, followed by group and individual sessions covering topics such as physical activity, fatigue, sleep and cognitive issues, mental health, sexuality and relationships, family and friends, nutrition, and education or work. Each participant will have a designated contact person nurse or physiotherapist who supports them throughout the programme. The control group will receive the usual cancer rehabilitation services, which include physical exercise. Fifty young adults who are undergoing or have completed curative-intent cancer treatment within the past five years will participate. Assessments will be done at baseline, and then at 4, 6, and 12 months after enrollment. Researchers will monitor recruitment, retention, acceptability of randomization, data completeness, assessment burden, and any adverse events. They will also gather preliminary data on health-related quality of life, young adult-specific quality of life, and self-efficacy. The total study duration extends to the end of 2028.

CONDITIONS

Brief Title

Evaluating the YATAC Programme

Research Team

M

Maria Aagesen, PhD

M

Marc Sampedro Pilegaard, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here